Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ?

@article{Francis2015IsSL,
  title={Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ?},
  author={Ashleigh M. Francis and Christine E Haugen and Lynn M. Grimes ANP and MS JaimeR.Crow and PhD Min Yi and PhD FACS Elizabeth A. Mittendorf and Isabelle Bedrosian and Abigail Suzanne Caudle and Gildy V. Babiera and Savitri Krishnamurthy and PhD FACS Henry M. Kuerer and Kelly K. Hunt},
  journal={Annals of Surgical Oncology},
  year={2015},
  volume={22},
  pages={4270-4279}
}
Positive sentinel lymph node (SLN) findings in ductal carcinoma in situ (DCIS) range from 1 to 22 % but have unknown biologic significance. This study sought to identify predictors of positive SLNs and to assess their clinical significance for patients with an initial diagnosis of DCIS. The study identified 1234 patients with an initial diagnosis of DCIS who underwent SLN dissection (SLND) at our institution from 1997 through 2011. Positive SLN findings were categorized as isolated tumor cells… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 36 references

Similar Papers

Loading similar papers…